Embryonic Stem Cell Human Clinical Trials in the U.S.

Last week, the FDA held meetings to discuss the implications of future human clinical trials using embryonic stem cells in the U.S. Their meeting titled, “Considerations for Safety Testing for Cellular Therapy Products Derived From Human Embryonic Stem Cell”, is just one step of many, in an area of research that is controversial, exciting, and relatively unexplored.

I’ve been spinal cord injured for almost fourteen years. It’s refreshing to finally see therapies moving from making rats and mice walk, to potentially help some like myself walk again.

The Student Society for Stem Cell Research comments, ‘The FDA hearings are particularly timely, as Geron is expected to begin human clinical trials using embryonic stem cells for the treatment of spinal cord injury this summer.

“We are talking about weeks, not years, before we see the first clinical trials using embryonic stem cells. This is inspiring to our generation and empowers our hope that the next generation will not have to endure many of today’s dreaded conditions for which stem cell research holds promise,” said Marion J. Riggs, SSSCR Founder.’

The human clinical trials proposed by Geron will be conducted on “acute”, or newly injured individuals.

Source - myquadriplegia.com

To contact one of our specialist lawyers please call 0800 61 66 81, or use the contact details at the top left of this page.